- Home
- HFBL vs CYCC Comparison
HFBL vs CYCC Comparison
Compare HFBL & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- CYCC
- Stock Information
- Founded
- HFBL 1924
- CYCC 1992
- Country
- HFBL United States
- CYCC Malaysia
- Employees
- HFBL N/A
- CYCC 12
- Industry
- HFBL Savings Institutions
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- CYCC Health Care
- Exchange
- HFBL Nasdaq
- CYCC Nasdaq
- Market Cap
- HFBL 41.7M
- CYCC 47.6M
- IPO Year
- HFBL N/A
- CYCC N/A
- Fundamental
- Price
- HFBL $13.35
- CYCC $0.22
- Analyst Decision
- HFBL
- CYCC Strong Buy
- Analyst Count
- HFBL 0
- CYCC 1
- Target Price
- HFBL N/A
- CYCC $11.00
- AVG Volume (30 Days)
- HFBL 3.6K
- CYCC 161.7K
- Earning Date
- HFBL 04-29-2025
- CYCC 05-13-2025
- Dividend Yield
- HFBL 3.90%
- CYCC N/A
- EPS Growth
- HFBL N/A
- CYCC N/A
- EPS
- HFBL 1.09
- CYCC N/A
- Revenue
- HFBL $19,713,000.00
- CYCC $43,000.00
- Revenue This Year
- HFBL N/A
- CYCC $137.21
- Revenue Next Year
- HFBL N/A
- CYCC N/A
- P/E Ratio
- HFBL $12.46
- CYCC N/A
- Revenue Growth
- HFBL N/A
- CYCC N/A
- 52 Week Low
- HFBL $10.60
- CYCC $0.17
- 52 Week High
- HFBL $14.08
- CYCC $4.00
- Technical
- Relative Strength Index (RSI)
- HFBL 55.00
- CYCC 41.53
- Support Level
- HFBL $13.10
- CYCC $0.17
- Resistance Level
- HFBL $13.57
- CYCC $0.32
- Average True Range (ATR)
- HFBL 0.10
- CYCC 0.02
- MACD
- HFBL 0.02
- CYCC 0.00
- Stochastic Oscillator
- HFBL 48.16
- CYCC 63.75
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.